Scientific Evidence is at the Heart of CHESS.
CHESS Health was co-founded by University of Wisconsin Professor David H. Gustafson, PhD, to bring to market the ACHESS smartphone app he had developed and validated in multiple clinical studies (see below). Today, CHESS’ eRecovery solution and its Connections App deliver the same innovative and proven ACHESS functionality, just under new names.
In 2018, CHESS Health expanded its offerings by partnering with Yale School of Medicine Professor Kathleen M. Carroll, PhD, to commercialize her innovative and clinically-validated online programs for patients to self-learn valuable cognitive behavioral therapy (CBT) skills critical to sustained recovery, which, in her clinical trials and resulting publications, are known as computer-based training for cognitive behavioral therapy (CBT4CBT). Today, CHESS’ eTherapy solution comprises Dr. Carroll’s CBT4CBT programs.
In total, CHESS’ technology for supporting the treatment and recovery from addiction have been the subject of more than ten randomized clinical trials with the important and positive findings the subject of dozens of publications.
Each year, CHESS’ technology is used by more researchers to study different use cases and implementations, ranging from use in a drug court program in Australia to the recovery of hospitalized inpatients suffering from endocarditis caused by severe opioid-related infection.